Recent News

• 05.01.2026 - Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
• 04.30.2026 - Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Recent Filings

• 04.30.2026 - 8-K Current report
• 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2026 - EX-99.1 EX-99.1
• 04.07.2026 - ARS Annual Report to Security Holders
• 04.07.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.07.2026 - DEF 14A Other definitive proxy statements
• 03.27.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 03.12.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities